Neuroscience
A company press release concerning an agreement to develop additional research efforts in the search for pharmaceutical treatments for brain tumors:
- Business World: Guilford Pharm's Gliadel
A company press release regarding a treatment for brain tumors: Guilford Pharmaceuticals Announces Orphan Drug Designation for GLIADEL(R) Wafer; Market Exclusivity for GLIADEL(R) Extends Until 2010 BALTIMORE, Sept. 27 /PRNewswire-FirstCall/ -- Guilford...
- Business World: Ecopia's Eco-4601 And The Blood-brain Barrier
This corporate press release on BusinessWire about a drug candidate for treatment of primary brain tumors: Ecopia's Lead Cancer Compound Shown to Cross Blood-Brain Barrier September 23, 2004 08:26 AM US Eastern Timezone ...
- Treating Dog Cancer
Today's New York Times has an article about dog cancer. Seems some dogs are participating in clinical trials to assess the effectiveness of cancer treatment in humans and animals. Those in which the treatment succeeds are indeed lucky dogs. If only...
- Focus On Brain Cancer: Discovery To Recovery
The Focus On Brain Cancer: Discovery to Recovery conference is sponsored by the Abramson Cancer Center. The Focus On Brain Cancer conference is for adults who are newly diagnosed, in treatment of survivors of brain cancer. At this conference, adults with...
- Dr. Brem Talks About High Recurrence Rate For Glioblastoma
Steven Brem, MDSteven Brem, MD, professor of Neurosurgery and director of Neurosurgical Oncology, is quoted in a Philly.com story detailing the outlook for patients who, like former Phillies catcher Darren Daulton, are diagnosed with the brain cancer...
Neuroscience
Business World: CombinatoRx and Brain Tumors
A company press release concerning an agreement to develop additional research efforts in the search for pharmaceutical treatments for brain tumors:
CombinatoRx and ABC2 Initiate Brain Cancer Collaboration: Partnership Speeds Search for Brain Cancer Cure
Monday September 27, 8:33 am ET
BOSTON and BURLINGAME, Calif., Sept. 27 /PRNewswire/ -- CombinatoRx, Incorporated, a privately held pharmaceutical company, and Accelerate Brain Cancer Cure (ABC2), a non-profit foundation dedicated to accelerating therapies leading to a cure for brain cancer, today announced that they have initiated a research collaboration aimed at identifying novel multi-target drugs for the treatment of brain cancer.
The sponsored research will leverage the CombinatoRx proprietary combination high throughput screening (cHTS) platform in an effort to discover novel drug combinations that hit multiple targets relevant to glioblastoma multiforme (GBM), a deadly form of brain cancer. The cHTS platform allows CombinatoRx to uncover synergistic activities of drug combinations acting on a network of molecular pathways.
[ ... Read the full press release ... ]
- Business World: Guilford Pharm's Gliadel
A company press release regarding a treatment for brain tumors: Guilford Pharmaceuticals Announces Orphan Drug Designation for GLIADEL(R) Wafer; Market Exclusivity for GLIADEL(R) Extends Until 2010 BALTIMORE, Sept. 27 /PRNewswire-FirstCall/ -- Guilford...
- Business World: Ecopia's Eco-4601 And The Blood-brain Barrier
This corporate press release on BusinessWire about a drug candidate for treatment of primary brain tumors: Ecopia's Lead Cancer Compound Shown to Cross Blood-Brain Barrier September 23, 2004 08:26 AM US Eastern Timezone ...
- Treating Dog Cancer
Today's New York Times has an article about dog cancer. Seems some dogs are participating in clinical trials to assess the effectiveness of cancer treatment in humans and animals. Those in which the treatment succeeds are indeed lucky dogs. If only...
- Focus On Brain Cancer: Discovery To Recovery
The Focus On Brain Cancer: Discovery to Recovery conference is sponsored by the Abramson Cancer Center. The Focus On Brain Cancer conference is for adults who are newly diagnosed, in treatment of survivors of brain cancer. At this conference, adults with...
- Dr. Brem Talks About High Recurrence Rate For Glioblastoma
Steven Brem, MDSteven Brem, MD, professor of Neurosurgery and director of Neurosurgical Oncology, is quoted in a Philly.com story detailing the outlook for patients who, like former Phillies catcher Darren Daulton, are diagnosed with the brain cancer...